Radicle Science OBX Pain study testing cannabinoids finds significant improvement

Radicle Science, in collaboration with Open Book Extracts (OBX), has released the results of the largest-ever clinical trial on cannabinoids for pain. As a B-corp healthtech company utilizing AI technology, Radicle Science conducted the study on health and wellness products. The trial involved over 1,600 participants from the United States and focused on examining the synergistic effects of rare cannabinoids, such as Cannabichromene (CBC) and Cannabigerol (CBG), alongside Cannabidiol (CBD). The formulations supplied by OBX, a certified manufacturer and distributor of high-quality cannabinoid ingredients, demonstrated clinically meaningful improvements in pain across different combinations of CBD and rare cannabinoids.

Read More